StockpollyBeta
Get App
Popularity #1,687
ABEO · NASDAQ · Biotechnology

Abeona Therapeutics (ABEO)

Commercializes ZEVASKYN for RDEB wounds through qualified treatment centers.

$5.56
vs last close−0.27 (−4.55%)

Something off on this page? Send us feedback.

13F · 13D/G · Form 4

Insiders11.68%6.68M shares
14 holders · as of Sep 1, 2026
Strategic holders14.93%8.54M shares
4 holders · as of Sep 30, 2025
Other73.39%41.97M shares
remainder

57.18M company shares as of Sep 23, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Nantahala Capital Management, LLCInstitution
10.10%5.78Mfiled May 15, 2026
Nantahala Capital Partners Limited PartnershipInstitution
5.83%3.33Mfiled May 15, 2026
Orin HirschmanInsider
5.42%3.10Mfiled Apr 28, 2026
Funicular Funds, LPInstitution
5.26%3.01Mfiled Apr 6, 2026
BlackRock, Inc.Strategic
5.16%2.95Mfiled Jul 17, 2025
James Russell Revocable TrustStrategic
4.76%2.72Mfiled Sep 30, 2025
Suvretta Capital Management, LLCStrategic
4.68%2.68Mfiled Aug 13, 2025
Vishwas SeshadriInsiderdirector, officer: Chief Executive Officer
2.28%1.31Mfiled Jul 9, 2026
Joseph Walter VazzanoInsiderofficer: Chief Financial Officer
0.86%492,079filed Jul 22, 2026
Brendan M. O'MalleyInsiderofficer: SVP, Chief Legal Officer
0.75%427,953filed Jul 9, 2026
Madhav VasanthavadaInsiderofficer: Chief Commercial Officer
0.51%290,623filed Jul 9, 2026
Michael AmorosoInsiderdirector
0.38%217,779filed Jan 27, 2026
FMR LLCStrategic
0.33%191,168filed Mar 12, 2018
Faith L. CharlesInsiderdirector
0.31%176,407filed Jan 27, 2026
Donald A. WuchterlInsiderdirector
0.29%167,935filed Feb 2, 2026
Leila AllandInsiderdirector
0.28%162,614filed Jul 2, 2026
Christine Berni SilversteinInsiderdirector
0.21%119,562filed Jun 15, 2026
T. Rowe Price Associates, Inc.Institution
0.18%101,982filed Feb 14, 2019
Bernhardt G. ZeiherInsiderdirector
0.15%84,458filed Jan 27, 2026
Mark AlvinoInsiderdirector
0.11%62,065filed Sep 1, 2026
Eric CrombezInsiderdirector
0.07%37,313filed May 15, 2026
Keith A. GoldanInsiderdirector
0.06%32,751filed Apr 7, 2026
Viking Global Investors LPInstitution
0.02%11,741filed Jan 10, 2019
Armistice Capital, LLCStrategic
—6.44% of class, as filed—filed Feb 14, 2023
Deerfield Partners, L.P.Institution
—5.06% of class, as filed—filed Nov 16, 2022

13F

No 13F holders on record.

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Nantahala Capital Management, LLC9.99%5.78M13GMay 15, 2026
Nantahala Capital Partners Limited Partnership5.82%3.33M13GMay 15, 2026
BlackRock, Inc.5.80%2.95M13GJul 17, 2025
Orin Hirschman5.40%3.10M13GApr 28, 2026
Funicular Funds, LP5.30%3.01M13GApr 6, 2026
James Russell Revocable Trust5.30%2.72M13GSep 30, 2025
Suvretta Capital Management, LLC5.20%2.68M13GAug 13, 2025
Daniel Kaufman5.16%2.94M13GMar 27, 2026

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Sep 1, 2026
Mark Alvinodirector
Sale15,000$5.8662,065
Jul 21, 2026
Joseph Walter Vazzanoofficer: Chief Financial Officer
Sale1,478$6.53492,079
Jul 9, 2026
Madhav Vasanthavadaofficer: Chief Commercial Officer
Sale12,606$6.96290,623
Jul 9, 2026
Brendan M. O'Malleyofficer: SVP, Chief Legal Officer
Sale12,050$6.96427,953
Jul 9, 2026
Vishwas Seshadridirector, officer: Chief Executive Officer
Sale67,971$6.961,306,108
Jul 9, 2026
Joseph Walter Vazzanoofficer: Chief Financial Officer
Sale24,880$6.96493,557
Jun 30, 2026
Leila Allanddirector
Sale11,000$5.92162,614
Jun 15, 2026
Christine Berni Silversteindirector
Sale18,160$5.71119,562
Jun 9, 2026
Vishwas Seshadridirector, officer: Chief Executive Officer
Sale31,916$5.301,374,079
Jun 8, 2026
Vishwas Seshadridirector, officer: Chief Executive Officer
Sale24,428$5.431,405,995

House and Senate disclosures

Not reported.